SCHEMBL1084784

SCHEMBL1084784

Oc1ccccc1-c1nc(N2CCC(N3CCCC3)CC2)c2cc(F)ccc2n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMAD3 P84022 1/20 0.58
CHEK2 O96017 3/20 0.52
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
ALDH1A1 P00352 4/20 0.47
MAPT P10636 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
TSHR P16473 2/20 0.47
HIF1A Q16665 3/20 0.47
ABCB1 P08183 1/20 0.42
PIK3CA P42336 3/20 0.41
MTOR P42345 1/20 0.41
KDM4E B2RXH2 3/20 0.40
TDP1 Q9NUW8 2/20 0.40
HSP90AA1 P07900 1/20 0.40
HPGD P15428 2/20 0.40
HSD17B10 Q99714 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
PIK3CD O00329 1/20 0.40
PIK3CG P48736 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1084650 0.99 SMAD3 (0.57) SMAD3CHEK2MEN1KMT2AALDH1A1
SCHEMBL1084362 0.92 SMAD3 (0.51) SMAD3CHEK2MEN1KMT2AALDH1A1
SCHEMBL1084082 0.91 CHEK2 (0.50) SMAD3CHEK2MEN1KMT2AALDH1A1
SCHEMBL1084501 0.91 CHEK2 (0.50) SMAD3CHEK2MEN1KMT2AALDH1A1
SCHEMBL12721527 0.89 SMAD3 (0.73) SMAD3CHEK2MEN1KMT2AALDH1A1
SCHEMBL1621893 0.86 SMAD3 (0.56) SMAD3CHEK2MEN1KMT2AALDH1A1
SCHEMBL1084207 0.84 SMAD3 (0.54) SMAD3CHEK2MEN1KMT2AALDH1A1
SCHEMBL1084712 0.84 SMAD3 (0.54) SMAD3CHEK2MEN1KMT2AALDH1A1
SCHEMBL1084618 0.84 SMAD3 (0.56) SMAD3CHEK2MEN1KMT2AALDH1A1
SCHEMBL1083988 0.84 CHEK2 (0.55) SMAD3CHEK2MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed